X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PANACEA BIOTECH - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PANACEA BIOTECH WYETH LTD/
PANACEA BIOTECH
 
P/E (TTM) x 27.7 179.7 15.4% View Chart
P/BV x 5.3 4.0 134.0% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PANACEA BIOTECH
Mar-14
WYETH LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,044149 702.4%   
Low Rs81882 993.9%   
Sales per share (Unadj.) Rs298.684.1 354.8%  
Earnings per share (Unadj.) Rs57.2-18.3 -312.7%  
Cash flow per share (Unadj.) Rs58.4-6.7 -872.0%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.583.7 298.0%  
Shares outstanding (eoy) m22.7261.25 37.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.4 227.2%   
Avg P/E ratio x16.3-6.3 -257.9%  
P/CF ratio (eoy) x15.9-17.2 -92.5%  
Price / Book Value ratio x3.71.4 270.5%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1577,074 299.1%   
No. of employees `0000.52.8 17.9%   
Total wages/salary Rs m4001,449 27.6%   
Avg. sales/employee Rs Th13,787.41,874.1 735.7%   
Avg. wages/employee Rs Th813.0527.0 154.3%   
Avg. net profit/employee Rs Th2,643.3-407.7 -648.3%   
INCOME DATA
Net Sales Rs m6,7835,154 131.6%  
Other income Rs m353100 353.3%   
Total revenues Rs m7,1365,254 135.8%   
Gross profit Rs m1,617-766 -211.1%  
Depreciation Rs m27711 3.7%   
Interest Rs m61,503 0.4%   
Profit before tax Rs m1,938-2,881 -67.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m-51,771 -0.3%   
Tax Rs m63217 3,763.1%   
Profit after tax Rs m1,301-1,121 -116.0%  
Gross profit margin %23.8-14.9 -160.3%  
Effective tax rate %32.6-0.6 -5,593.8%   
Net profit margin %19.2-21.8 -88.1%  
BALANCE SHEET DATA
Current assets Rs m6,9843,810 183.3%   
Current liabilities Rs m2,0568,365 24.6%   
Net working cap to sales %72.6-88.4 -82.2%  
Current ratio x3.40.5 745.8%  
Inventory Days Days99156 63.8%  
Debtors Days Days2467 35.6%  
Net fixed assets Rs m24414,480 1.7%   
Share capital Rs m22761 370.6%   
"Free" reserves Rs m5,441903 602.5%   
Net worth Rs m5,6685,127 110.5%   
Long term debt Rs m255,832 0.4%   
Total assets Rs m7,90119,433 40.7%  
Interest coverage x353.3-0.9 -38,551.8%   
Debt to equity ratio x01.1 0.4%  
Sales to assets ratio x0.90.3 323.7%   
Return on assets %16.52.0 841.6%  
Return on equity %22.9-21.9 -104.9%  
Return on capital %34.03.6 936.3%  
Exports to sales %0.224.5 0.9%   
Imports to sales %36.310.2 356.9%   
Exports (fob) Rs m151,264 1.2%   
Imports (cif) Rs m2,465525 469.8%   
Fx inflow Rs m151,539 1.0%   
Fx outflow Rs m2,677942 284.2%   
Net fx Rs m-2,662597 -445.7%   
CASH FLOW
From Operations Rs m923599 154.1%  
From Investments Rs m317-438 -72.4%  
From Financial Activity Rs m-481-303 159.0%  
Net Cashflow Rs m759-141 -537.2%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.6 1,883.3%  
FIIs % 7.2 1.3 553.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 23.6 128.8%  
Shareholders   21,978 10,259 214.2%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 300 Points; Tata Steel Up 3.5%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels. Sectoral indices are trading on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - DR. REDDYS LAB COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS